The therapeutic candidate is under development for the treatment of liver fibrosis and KRAS-driven liver cancer. It is an antisense RNAi oligonucleotide delivered through lipid-nanoparticles and is ...

Integrating AI with flow cytometry revolutionizes drug discovery and oncology, offering precise cell analysis and real-time ...